Metabolic pathways in Magnetospirillum gryphiswaldense MSR-1 are significantly altered under microaerobic (O 2 -limited) growth conditions enabling magnetosome formation.
We have investigated the applicability of commercially available lyophilised Spirulina (Arthrospira platensis), a microorganism uniformly labelled with 13C, as a readily accessible source of multiple 13C-labelled metabolites suitable as internal standards for quantitative determination of intracellular bacterial metabolites. Metabolites of interest were analysed by hydrophilic interaction liquid chromatography coupled with high resolution mass spectrometry. Multiple internal standards obtained from uniformly (U)-13C-labelled extract from Spirulina were used to enable isotope dilution mass spectrometry (IDMS) for the identification and quantification of the intracellular metabolites. Extraction of intracellular metabolites of C. autoethanogenum using 2:1:1 chloroform:methanol:water was found optimum in comparison to freeze-thaw, homogenisation, and sonication methods. Limits of quantification were ≤ 1 µM with excellent linearity of all calibration curves (r2 ≥ 0.99) for 74 metabolites. Precision and accuracy were found to be within a relative standard deviation (RSD) of 15% for 49 of the metabolites and within an RSD 20% for all metabolites. The method was applied to study the effect over 35 days of feeding different levels of carbon monoxide (as carbon source) on the central metabolism and the Wood-Ljungdahl pathway of C. autoethanogenum grown in continuous culture. LC-IDMS using U-13C Spirulina successfully quantified 52 metabolites in the samples including amino acids, carboxylic acids, sugar phosphates, purines, and pyrimidines. The method provided absolute quantitative data on intracellular metabolites suitable for computational modelling to understand and optimise the metabolic pathways of C. autoethanogenum active in gas fermentation.
Phospholipid-modified gold nanorods (phospholipid-GNRs) have demonstrated drastic cytotoxicity towards MCF-7 breast cancer cells compared to polyethylene glycol-coated GNRs (PEG-GNRs). In this study, the mechanism of cytotoxicity of phospholipid-GNRs towards MCF-7 cells was investigated using mass spectrometry-based global metabolic profiling and compared to PEGylated counterparts. The results showed that when compared to PEG-GNRs, phospholipid-GNRs induced significant and more pronounced impact on the metabolic profile of MCF-7 cells. Phospholipid-GNRs significantly decreased the levels of metabolic intermediates and end-products associated with cellular energy metabolisms resulting in dysfunction in TCA cycle, a reduction in glycolytic activity, and imbalance of the redox state. Additionally, phospholipid-GNRs disrupted several metabolism pathways essential for the normal growth and proliferation of cancer cells including impairment in purine, pyrimidine, and glutathione metabolisms accompanied by lower amino acid pools. On the other hand, the effects of PEG-GNRs were limited to alteration of glycolysis and pyrimidine metabolism. The current work shed light on the importance of metabolomics as a valuable analytical approach to explore the molecular effects of GNRs with different surface chemistry on cancer cell and highlights metabolic targets that might serve as promising treatment strategy in cancer.
Ethylene is a small hydrocarbon gas widely used in the chemical industry. Annual worldwide production currently exceeds 150 million tons, producing considerable amounts of CO2 contributing to climate change. The need for a sustainable alternative is therefore imperative. Ethylene is natively produced by several different microorganisms, including Pseudomonas syringae pv. phaseolicola via a process catalyzed by the ethylene-forming enzyme (EFE), subsequent heterologous expression of EFE has led to ethylene production in non-native bacterial hosts including Escherichia coli and cyanobacteria. However, solubility of EFE and substrate availability remain rate-limiting steps in biological ethylene production. We employed a combination of genome-scale metabolic modelling, continuous fermentation, and protein evolution to enable the accelerated development of a high efficiency ethylene producing E. coli strain, yielding a 49-fold increase in production, the most significant improvement reported to date. Furthermore, we have clearly demonstrated that this increased yield resulted from metabolic adaptations that were uniquely linked to EFE (wild type versus mutant). Our findings provide a novel solution to deregulate metabolic bottlenecks in key pathways, which can be readily applied to address other engineering challenges.